Association of Intravenous Thrombolysis with Delayed Reperfusion After Incomplete Mechanical Thrombectomy

Clin Neuroradiol. 2023 Mar;33(1):87-98. doi: 10.1007/s00062-022-01186-7. Epub 2022 Jul 14.

Abstract

Purpose: Treatment of distal vessel occlusions causing incomplete reperfusion after mechanical thrombectomy (MT) is debated. We hypothesized that pretreatment with intravenous thrombolysis (IVT) may facilitate delayed reperfusion (DR) of residual vessel occlusions causing incomplete reperfusion after MT.

Methods: Retrospective analysis of patients with incomplete reperfusion after MT, defined as extended thrombolysis in cerebral infarction (eTICI) 2a-2c, and available perfusion follow-up imaging at 24 ± 12 h after MT. DR was defined as absence of any perfusion deficit on time-sensitive perfusion maps, indicating the absence of any residual occlusion. The association of IVT with the occurrence of DR was evaluated using a logistic regression analysis adjusted for confounders. Sensitivity analyses based on IVT timing (time between IVT start and the occurrence incomplete reperfusion following MT) were performed.

Results: In 368 included patients (median age 73.7 years, 51.1% female), DR occurred in 225 (61.1%). Atrial fibrillation, higher eTICI grade, better collateral status and longer intervention-to-follow-up time were all associated with DR. IVT did not show an association with the occurrence of DR (aOR 0.80, 95% CI 0.44-1.46, even in time-sensitive strata, aOR 2.28 [95% CI 0.65-9.23] and aOR 1.53 [95% CI 0.52-4.73] for IVT to incomplete reperfusion following MT timing <80 and <100 min, respectively).

Conclusion: A DR occurred in 60% of patients with incomplete MT at ~24 h and did not seem to occur more often in patients receiving pretreatment IVT. Further research on potential associations of IVT and DR after MT is required.

Keywords: Incomplete Reperfusion; Ischemic stroke; Outcome; Perfusion imaging; Tissue-type plasminogen activator; tPA.

MeSH terms

  • Aged
  • Brain Ischemia* / therapy
  • Cerebral Infarction / drug therapy
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Mechanical Thrombolysis*
  • Reperfusion
  • Retrospective Studies
  • Stroke* / diagnostic imaging
  • Stroke* / drug therapy
  • Thrombectomy
  • Thrombolytic Therapy
  • Treatment Outcome

Substances

  • Fibrinolytic Agents